As of Mar 27
| +0.09 / +1.27%|
The 4 analysts offering 12-month price forecasts for Genesis Healthcare Inc have a median target of 8.50, with a high estimate of 11.00 and a low estimate of 8.00. The median estimate represents a +18.22% increase from the last price of 7.19.
The current consensus among 5 polled investment analysts is to Hold stock in Genesis Healthcare Inc. This rating has held steady since March, when it was downgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.